| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |